Description
DENVER IMMUNOHISTOLOGICAL AND GENETIC TESTING DE-OBLIGATING FUNDS
Base award description: IGF::CT::IGF IMMUNOHISTOLOGICAL AND GENETIC TESTING
Modification chain · 14 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-12-04+$185,055= $185,055
- Mod P000012015-09-24+$40,000= $225,055
- Mod P000022015-12-15+$185,055= $410,111
- Mod P000042016-08-24-$111,721= $298,390
- Mod P000052016-12-06+$194,308= $492,698
- Mod P000062018-01-01+$204,024= $696,722
- Mod P000072018-10-15+$0= $696,722
- Mod P000082019-01-01+$214,225= $910,947
- Mod P000102019-12-11+$30,000= $940,947
- Mod P000092019-12-26-$162,463= $778,484
- Mod P000112020-03-27+$30,000= $808,484
- Mod P000142021-11-21-$103,944= $704,541
- Mod P000152022-02-24-$138,422= $566,119
- Mod P000132022-03-03-$37,442= $528,677
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-12-04 | +$185,055 | $185,055 | IGF::CT::IGF IMMUNOHISTOLOGICAL AND GENETIC TESTING |
| Mod P00001· FUNDING ONLY ACTION | 2015-09-24 | +$40,000 | $225,055 | IGF::CT::IGF IMMUNOHISTOLOGICAL AND GENETIC TESTING INCREASE TO BASE YEAR FUNDS |
| Mod P00002· EXERCISE AN OPTION | 2015-12-15 | +$185,055 | $410,111 | IGF::CT::IGF IMMUNOHISTOLOGICAL AND GENETIC TESTING OPTION YEAR 1 |
| Mod P00004· FUNDING ONLY ACTION | 2016-08-24 | −$111,721 | $298,390 | IGF::CT::IGF IMMUNOHISTOLOGICAL AND GENETIC TESTING PO DECREASE |
| Mod P00005· EXERCISE AN OPTION | 2016-12-06 | +$194,308 | $492,698 | IGF::CT::IGF IMMUNOHISTOLOGICAL AND GENETIC TESTING OPTION 2 |
| Mod P00006· EXERCISE AN OPTION | 2018-01-01 | +$204,024 | $696,722 | IGF::CT::IGF IMMUNOHISTOLOGICAL AND GENETIC TESTING OPTION 3 |
| Mod P00007· NOVATION AGREEMENT | 2018-10-15 | +$0 | $696,722 | IGF::CT::IGF IMMUNOHISTOLOGICAL AND GENETIC TESTING NOVATION AGREEMENT |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-01-01 | +$214,225 | $910,947 | IGF::CT::IGF IMMUNOHISTOLOGICAL AND GENETIC TESTING NOVATION AGREEMENT OPTION 4 |
| Mod P00010· EXERCISE AN OPTION | 2019-12-11 | +$30,000 | $940,947 | IMMUNOHISTOLOGICAL AND GENETIC TESTING NOVATION AGREEMENT OPTION TO EXTEND SERVICES |
| Mod P00009· FUNDING ONLY ACTION | 2019-12-26 | −$162,463 | $778,484 | IMMUNOHISTOLOGICAL AND GENETIC TESTING NOVATION AGREEMENT OPTION 4 |
| Mod P00011· EXERCISE AN OPTION | 2020-03-27 | +$30,000 | $808,484 | IMMUNOHISTOLOGICAL AND GENETIC TESTING OPTION TO EXTEND SERVICES AND PO FUNDING INCREASE |
| Mod P00014· FUNDING ONLY ACTION | 2021-11-21 | −$103,944 | $704,541 | DENVER IMMUNOHISTOLOGICAL AND GENETIC TESTING DE-OBLIGATING FUNDS |
| Mod P00015· FUNDING ONLY ACTION | 2022-02-24 | −$138,422 | $566,119 | DENVER IMMUNOHISTOLOGICAL AND GENETIC TESTING DE-OBLIGATING FUNDS |
| Mod P00013· FUNDING ONLY ACTION | 2022-03-03 | −$37,442 | $528,677 | DENVER IMMUNOHISTOLOGICAL AND GENETIC TESTING DE-OBLIGATING FUNDS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ML9LFC5CK7K9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0390 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $493,650 | FY2026 |
| 36C25926N0228 | NETWORK CONTRACT OFFICE 19 (36C259) · Q301 · REFERENCE LABORATORY TESTING | $100,000 | FY2026 |
| 36C26126N0417 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q301 · REFERENCE LABORATORY TESTING | $643,694 | FY2026 |
| 36C26126D0032 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2026 |
| 36C24126N0285 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · Q301 · REFERENCE LABORATORY TESTING | $500,000 | FY2026 |
| 36C26126N0169 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q301 · REFERENCE LABORATORY TESTING | $325,000 | FY2026 |
Other recipients under Q301 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25926A0033 | NATERA INC | NETWORK CONTRACT OFFICE 19 (36C259) | $0 | FY2026 |
| 36C25926N0444 | ST. MARY'S HOSPITAL & MEDICAL CENTER, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $78,399 | FY2026 |
| 36C25926N0463 | NATERA INC | NETWORK CONTRACT OFFICE 19 (36C259) | $40,000 | FY2026 |
| 36C25926F0235 | LABORATORY CORPORATION OF AMERICA | NETWORK CONTRACT OFFICE 19 (36C259) | $880,000 | FY2026 |
| 36C25926N0374 | UNIVERSITY PHYSICIANS, INCORPORATED | NETWORK CONTRACT OFFICE 19 (36C259) | $6,050 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25915C0007_3600_-NONE-_-NONE- · retrieved 2026-09-26.